Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart J A Rijnders

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
AIDS Research and Human Retroviruses|January 28, 2015
Short communication: Lipids and cardiovascular risk after switching HIV-1 patients on nevirapine and emtricitabine/tenofovir-DF to rilpivirine/emtricitabine/tenofovir-DFCasper Rokx, Annelies Verbon, Bart J A Rijnders
Pulmonary Pharmacology & Therapeutics|October 28, 2008
Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trialLennert Slobbe, Eric Boersma, Bart J A Rijnders
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 12, 2022
Evidence-based dosing of convalescent plasma for COVID-19 in future trialsBart J A Rijnders, Sammy Huygens, Oriol Mitjà
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2002
Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence?Bart J A Rijnders, Eric Van Wijngaerden, Willy E Peetermans
Journal of Clinical Microbiology|January 28, 2009
Comparison of the roll plate method to the sonication method to diagnose catheter colonization and bacteremia in patients with long-term tunnelled catheters: a randomized prospective studyLennert Slobbe, Abdelilah El Barzouhi, Eric Boersma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Use of full sterile barrier precautions during insertion of arterial catheters: a randomized trialBart J A Rijnders, Eric Van Wijngaerden, Alexander Wilmer, et al.
Journal of the International AIDS Society|April 11, 2018
Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?Natasha K Martin, Anne Boerekamps, Andrew M Hill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2014
The efficacy, pharmacokinetics, and safety of a nevirapine to rilpivirine switch in virologically suppressed HIV-1-infected patientsCasper Rokx, Maren Blonk, Annelies Verbon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2013
Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patientsCasper Rokx, Marchina E van der Ende, Annelies Verbon, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2016
Dolutegravir as maintenance monotherapy: first experiences in HIV-1 patientsCasper Rokx, Carolina A M Schurink, Charles A B Boucher, et al.
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
AIDS Research and Human Retroviruses|January 28, 2015
Short communication: Lipids and cardiovascular risk after switching HIV-1 patients on nevirapine and emtricitabine/tenofovir-DF to rilpivirine/emtricitabine/tenofovir-DFCasper Rokx, Annelies Verbon, Bart J A Rijnders
Pulmonary Pharmacology & Therapeutics|October 28, 2008
Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trialLennert Slobbe, Eric Boersma, Bart J A Rijnders
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 12, 2022
Evidence-based dosing of convalescent plasma for COVID-19 in future trialsBart J A Rijnders, Sammy Huygens, Oriol Mitjà
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 18, 2002
Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence?Bart J A Rijnders, Eric Van Wijngaerden, Willy E Peetermans
Journal of Clinical Microbiology|January 28, 2009
Comparison of the roll plate method to the sonication method to diagnose catheter colonization and bacteremia in patients with long-term tunnelled catheters: a randomized prospective studyLennert Slobbe, Abdelilah El Barzouhi, Eric Boersma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Use of full sterile barrier precautions during insertion of arterial catheters: a randomized trialBart J A Rijnders, Eric Van Wijngaerden, Alexander Wilmer, et al.
Journal of the International AIDS Society|April 11, 2018
Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?Natasha K Martin, Anne Boerekamps, Andrew M Hill, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 24, 2014
The efficacy, pharmacokinetics, and safety of a nevirapine to rilpivirine switch in virologically suppressed HIV-1-infected patientsCasper Rokx, Maren Blonk, Annelies Verbon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2013
Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patientsCasper Rokx, Marchina E van der Ende, Annelies Verbon, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2016
Dolutegravir as maintenance monotherapy: first experiences in HIV-1 patientsCasper Rokx, Carolina A M Schurink, Charles A B Boucher, et al.
Pageof 10